Chan Henry Lee - Sep 30, 2024 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role: SVP, General Counsel
Signature: /s/ Qing Nian, as Attorney-in-Fact
Stock symbol: BGNE
Transactions as of: Sep 30, 2024
Transactions value $: -$284,994
Form type: 4
Date filed: 10/2/2024, 07:13 PM
Previous filing: Aug 1, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BGNE	American Depositary Shares	Sale	-$285K	-1.2K	-100%	$237.10	0	Sep 30, 2024	Direct	F1, F2
holding	BGNE	Ordinary Shares						237K	Sep 30, 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	Each American Depositary Share represents 13 Ordinary Shares.
F2	The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2023, as most recently amended on February 28, 2024.